skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,559  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Female remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
Material Type:
Article
Add to My Research

Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

The Lancet Diabetes & Endocrinology, 2020-10 [Peer Reviewed Journal]

2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/S2213-8587(20)30272-2

Digital Resources/Online E-Resources

2
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
Material Type:
Article
Add to My Research

Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

The Lancet Diabetes & Endocrinology, 2020-10 [Peer Reviewed Journal]

2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/S2213-8587(20)30271-0

Digital Resources/Online E-Resources

3
Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis
Material Type:
Article
Add to My Research

Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis

European journal of epidemiology, 2018-09, Vol.33 (9), p.811-829 [Peer Reviewed Journal]

Springer Nature B.V. 2018 ;The Author(s) 2018 ;European Journal of Epidemiology is a copyright of Springer, (2018). All Rights Reserved. © 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0393-2990 ;EISSN: 1573-7284 ;DOI: 10.1007/s10654-018-0380-1 ;PMID: 29589226

Full text available

4
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Material Type:
Article
Add to My Research

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

The New England journal of medicine, 2016-07, Vol.375 (4), p.311-322 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1603827 ;PMID: 27295427

Full text available

5
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study
Material Type:
Article
Add to My Research

Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study

Diabetes care, 2020-07, Vol.43 (7), p.1382-1391 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association Jul 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-0598 ;PMID: 32409504

Full text available

6
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Material Type:
Article
Add to My Research

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes

The New England journal of medicine, 2018-08, Vol.379 (7), p.633-644 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1800256 ;PMID: 30110583

Full text available

7
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program
Material Type:
Article
Add to My Research

Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program

Circulation (New York, N.Y.), 2018-07, Vol.138 (5), p.458-468 [Peer Reviewed Journal]

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 The Authors. 2018 ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.034222 ;PMID: 29526832

Full text available

8
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Material Type:
Article
Add to My Research

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

The New England journal of medicine, 2015-11, Vol.373 (22), p.2117-2128 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1504720 ;PMID: 26378978

Full text available

9
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Material Type:
Article
Add to My Research

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

Circulation (New York, N.Y.), 2019-05, Vol.139 (22), p.2528-2536 [Peer Reviewed Journal]

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.040130 ;PMID: 30882238

Full text available

10
Excess Mortality among Persons with Type 2 Diabetes
Material Type:
Article
Add to My Research

Excess Mortality among Persons with Type 2 Diabetes

The New England journal of medicine, 2015-10, Vol.373 (18), p.1720-1732 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1504347 ;PMID: 26510021

Full text available

11
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
Material Type:
Article
Add to My Research

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

The New England journal of medicine, 2017-04, Vol.376 (15), p.1407-1418 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1608664 ;PMID: 28402770

Full text available

12
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
Material Type:
Article
Add to My Research

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)

Circulation (New York, N.Y.), 2017-07, Vol.136 (3), p.249-259 [Peer Reviewed Journal]

2017 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2017 The Authors. ;2017 The Authors. 2017 ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.029190 ;PMID: 28522450

Full text available

13
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Material Type:
Article
Add to My Research

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

Diabetes care, 2018-02, Vol.41 (2), p.356-363 [Peer Reviewed Journal]

2017 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc17-1096 ;PMID: 29203583

Full text available

14
Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis
Material Type:
Article
Add to My Research

Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis

Diabetes care, 2016-11, Vol.39 (11), p.1987-1995 [Peer Reviewed Journal]

2016 by the American Diabetes Association. ;Copyright American Diabetes Association Nov 1, 2016 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc16-0614 ;PMID: 27493134 ;CODEN: DICAD2

Full text available

15
Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes
Material Type:
Article
Add to My Research

Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes

Cell Metabolism, 2021-01, Vol.33 (1), p.65-77.e2 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2020.11.014 ;PMID: 33248471

Digital Resources/Online E-Resources

16
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
Material Type:
Article
Add to My Research

Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial

Diabetologia, 2016-11, Vol.59 (11), p.2298-2307 [Peer Reviewed Journal]

The Author(s) 2016 ;Springer-Verlag Berlin Heidelberg 2016 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-016-4065-6 ;PMID: 27531506

Full text available

17
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017
Material Type:
Article
Add to My Research

Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017

Cardiovascular diabetology, 2018-06, Vol.17 (1), p.83-83, Article 83 [Peer Reviewed Journal]

Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-018-0728-6 ;PMID: 29884191

Full text available

18
Association of Type 2 Diabetes With Cancer: A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People
Material Type:
Article
Add to My Research

Association of Type 2 Diabetes With Cancer: A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People

Diabetes care, 2020-09, Vol.43 (9), p.2313-2322 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association Sep 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-0204 ;PMID: 32910779

Full text available

19
Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19
Material Type:
Article
Add to My Research

Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19

Diabetes care, 2020-12, Vol.43 (12), p.2938-2944 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association Dec 1, 2020 ;2020 by the American Diabetes Association 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-1506 ;PMID: 32847827

Full text available

20
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial
Material Type:
Article
Add to My Research

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial

Circulation (New York, N.Y.), 2019-03, Vol.139 (11), p.1384-1395 [Peer Reviewed Journal]

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 The Authors. 2018 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.037778 ;PMID: 30586757

Full text available

Results 1 - 20 of 1,559  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,491)

Refine My Results

Creation Date 

From To
  1. Before 1991  (28)
  2. 1991 To 1998  (83)
  3. 1999 To 2006  (198)
  4. 2007 To 2015  (709)
  5. After 2015  (542)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,558)
  2. magazinearticle  (1)
  3. More options open sub menu

Language 

  1. English  (1,536)
  2. Japanese  (202)
  3. Spanish  (14)
  4. Portuguese  (10)
  5. German  (6)
  6. Italian  (1)
  7. Russian  (1)
  8. Norwegian  (1)
  9. More options open sub menu

Searching Remote Databases, Please Wait